Albuquerque, NM, United States of America

Nathaniel P Chongsiriwatana

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Northwestern University, University of California. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathaniel P Chongsiriwatana. Retrieved from https://idiyas.com/inventor/nathaniel-p-chongsiriwatana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathaniel P Chongsiriwatana: Innovator in Antimicrobial Peptoid Compounds

Introduction

Nathaniel P Chongsiriwatana is a notable inventor based in Albuquerque, NM. He has made significant contributions to the field of antimicrobial research, particularly through his innovative work on peptoid compounds.

Latest Patents

Chongsiriwatana holds a patent for "Selective poly-N-substituted glycine antibiotics." This patent focuses on antimicrobial peptoid compounds and related compositions that can effectively and selectively combat bacteria. His work in this area has the potential to lead to advancements in antibiotic treatments.

Career Highlights

Throughout his career, Nathaniel has worked with prestigious institutions such as the University of California and Northwestern University. His experience in these academic environments has allowed him to develop and refine his research in antimicrobial agents.

Collaborations

Chongsiriwatana has collaborated with esteemed colleagues, including Annelise E Barron and Ann M Czyzewski. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his innovations in the field.

Conclusion

Nathaniel P Chongsiriwatana is a distinguished inventor whose work on antimicrobial peptoid compounds represents a significant advancement in the fight against bacterial infections. His contributions to science and collaboration with leading researchers highlight his commitment to innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…